Clinical Trial Update: Trial of Ateronon in Patients With Coronary Disease to Evaluate Its Effectiveness in Assessing the Risk Factors of Atherosclerosis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial of Ateronon in patients with coronary disease to evaluate its effectiveness in assessing risk factors for atherosclerosis has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Coronary Artery Disease

Drugs mentioned

• Ateronon

Snippet

Sponsor: Omicron Pharmaceuticals | Conditions: Atherosclerosis | Phase 3 | Status: COMPLETED